CARA THERAPEUTICS

Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on pruritus as well as pain by selectively targeting peripheral kappa opioid receptors. The company is developing a proprietary class of product candidates, led by KORSUVA (CR845/difelikefalin), a kappa opioid receptor agonist that targets the body's peripheral nervous system, as well as certain immune cells. The company's primary product candidate, CR845/difelikefalin, is a chemical entity, which is designed to selectively stimulate kappa, rather than mu, and delta opioid receptors outside of the CNS.
  • TickerCARA
  • ISINUS1407551092
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for CARA

ValuEngine Rating and Forecast Report for CARA

ValuEngine Rating and Forecast Report for CARA

ValuEngine Rating and Forecast Report for CARA

ValuEngine Rating and Forecast Report for CARA

ValuEngine Rating and Forecast Report for CARA

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Feasibility Study Results in December to be a Catalyst for this Junior

Feasibility Study Results in December to be a Catalyst for this Junior

Jonathan Moreland

InsiderInsights Daily Ratings Report: January 4, 2019

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process